NYSE · WLK

Westlake Corporation

$72.33 -$1.49 (-2.02%) 1D After hours

Key Metrics

$9.46B
Market cap
P/E · TTM
$10.98B
Revenue · TTM
−$1.64B
Net income
EPS · TTM $-12.76
Dividend yield 2.9%
Free cash flow −$508.00M
Beta · 1Y 0.69
EBITDA · TTM −$574.00M
Gross margin 6.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Apr 7 high, the share price fell 41%.

    Peak close $123.39 on Apr 7; trough close $72.33 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -41%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 5
    The stock moved -8.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 5
  • Feb 24
    The stock moved +12.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 24

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$9.46B
Enterprise value$12.55B
Shares outstanding128.1M
52-wk range$56.33 – $124.23
Avg volume · 20D732.5K
Net cash −$3.09B
Book value / share$66.61
IndustryIndustrial Organic Chemicals
ExchangeNYSE
About Westlake Corporation
IPO dateAug 11, 2004
Employees14600

Westlake is a forward-integrated commodity chemicals firm based in Houston. It began as a single low-density polyethylene plant and expanded its capabilities to include ethylene, vinyl chloride monomers, and polyvinyl chloride over the next two decades.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.86
P/FCF
EV/EBITDA
EV/Sales1.14
Graham №

Profitability

Gross 6.3%
Operating -16.0%
Net -14.9%
FCF -4.6%
ROE / ROIC -17.2% · -13.7%

Financial Health

Current ratio2.17
Quick ratio1.56
Debt / equity0.65
Debt / EBITDA -9.70
Net cash −$3.09B
Working capital$3.21B

Cash Flow · TTM

Operating CF $448.00M
Capex −$956.00M
Free cash flow −$508.00M
Buybacks $33.00M
Dividends paid $272.00M
Shareholder yield 3.2%

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

1.6
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings